Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Appelbaum

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Circulation|January 1, 2013
Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of ageBarry J Maron, Ethan J Rowin, Susan A Casey, et al.
Circulation. Cardiovascular Imaging|May 8, 2012
Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathyMartin S Maron, Ethan J Rowin, David Lin, et al.
Circulation. Cardiovascular Imaging|December 3, 2011
Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathyEvan Appelbaum, Barry J Maron, Selcuk Adabag, et al.
Journal of the American College of Cardiology|May 7, 2013
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathyIacopo Olivotto, Barry J Maron, Benedetta Tomberli, et al.
Clinical Trials (London, England)|April 12, 2011
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney diseaseYili Pritchett, Yannis Jemiai, Yuchiao Chang, et al.
American Journal of Nephrology|January 19, 2011
Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney diseaseRavi Thadhani, Evan Appelbaum, Yuchiao Chang, et al.
Circulation. Cardiovascular Imaging|February 15, 2017
Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic CardiomyopathyAdaya Weissler-Snir, Waseem Hindieh, Christiane Gruner, et al.
Circulation. Cardiovascular Genetics|August 12, 2017
Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset PhenotypesBerglind Adalsteinsdottir, Runolfur Palsson, Robert J Desnick, et al.
Circulation|August 3, 2016
Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical TrialBobak Heydari, Shuaib Abdullah, James V Pottala, et al.
JAMA|February 17, 2012
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trialRavi Thadhani, Evan Appelbaum, Yili Pritchett, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Circulation|January 1, 2013
Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of ageBarry J Maron, Ethan J Rowin, Susan A Casey, et al.
Circulation. Cardiovascular Imaging|May 8, 2012
Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathyMartin S Maron, Ethan J Rowin, David Lin, et al.
Circulation. Cardiovascular Imaging|December 3, 2011
Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathyEvan Appelbaum, Barry J Maron, Selcuk Adabag, et al.
Journal of the American College of Cardiology|May 7, 2013
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathyIacopo Olivotto, Barry J Maron, Benedetta Tomberli, et al.
Clinical Trials (London, England)|April 12, 2011
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney diseaseYili Pritchett, Yannis Jemiai, Yuchiao Chang, et al.
American Journal of Nephrology|January 19, 2011
Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney diseaseRavi Thadhani, Evan Appelbaum, Yuchiao Chang, et al.
Circulation. Cardiovascular Imaging|February 15, 2017
Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic CardiomyopathyAdaya Weissler-Snir, Waseem Hindieh, Christiane Gruner, et al.
Circulation. Cardiovascular Genetics|August 12, 2017
Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset PhenotypesBerglind Adalsteinsdottir, Runolfur Palsson, Robert J Desnick, et al.
Circulation|August 3, 2016
Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical TrialBobak Heydari, Shuaib Abdullah, James V Pottala, et al.
JAMA|February 17, 2012
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trialRavi Thadhani, Evan Appelbaum, Yili Pritchett, et al.
Pageof 6